Fall 2020 Coronavirus: Research, Policy & Clinical Perspectives
The Coronavirus (COVID-19) pandemic has upended all facets of life across the globe: from healthcare, to the economy and labor workforce, to education, to international relations. While researchers are rushing to understand the virus and develop a vaccine, the response from different nations throughout the world have influenced how individuals are navigating and curbing the spread of COVID-19. Join us for a discussion of interdisciplinary perspectives in global health to better understand this pandemic!
The UC San Diego Global Health Program and Students for Global Health held our thirteenth event in Quarterly Conversations in Global Health on Thursday, October 15th, 2020 through Zoom! This quarter’s panel spoke to the topic of Coronavirus and the research, policy, and clinical perspectives behind the pandemic.
Quarterly Conversations provides a forum for the Global Health community to come together to discuss relevant issues in the field from an interdisciplinary perspective and increase community interaction at UC San Diego.
Thank you to the community tables who participated in the event’s networking session: Health Frontiers in Tijuana (HFiT), International Health Collective, SNative American Student Alliance, UCSD Counseling and Psychological Services (CAPS), and Students for Global Health.
We would like to give our special appreciation to our event co-sponsors: UC San Diego Global Health Institute, UC San Diego Division of Social Sciences, UC San Diego Global Health Program, UC San Diego Associated Students, and UC San Diego Center for Global Mental Health.
The Fall 2020 Quarterly Conversations in Global Health featured four panelists who presented their research, insights and experiences on various health issues as they pertain to the field of Global Mental Health.
We were delighted to have Dr. Thomas Csordas, Director of UC San Diego’s Global Health Program, moderating the event as our Master of Ceremonies.
Dr. Robert T Schooley, MD
Dr. Schooley completed medical school and internal medicine residency at Johns Hopkins and infectious disease fellowships at the NIH and Massachusetts General Hospital. He joined the faculty of Harvard Medical School in 1981. He has been heavily involved in the development of antiviral chemotherapy directed at HIV, HCV and the herpesgroup viruses as well as in research, teaching and infrastructure building efforts in sub-Saharan Africa. He became Head of the Division of Infectious Diseases at the University of Colorado in 1990. He led the NIH’s AIDS Clinical Trials Group (ACTG) from 1995 until 2002 during which time the ACTG performed many of the seminal studies that defined modern antiretroviral chemotherapy. He was recruited to the University of California San Diego and served as Head of UCSD’s Infectious Diseases Division until 2017. He now serves as Senior Director of International Initiatives for the University of California San Diego and has become deeply engaged in the University’s response to the SARS CoV-2 outbreak.
Dr. Mia Lozada, MD
Dr. Mia Lozada was raised in Honolulu, Hawaii and has worked at Gallup Indian Medical Center (Indian Health Service) in New Mexico as a General Internist (a mix of primary care and hospital/ICU medicine) since August 2012. She leads the Internal Medicine Department’s Quality/Performance Improvement initiatives, spearheads the Readmissions Task Force and started the first Schwartz Center Rounds site in New Mexico at GIMC for staff well-being. She is Board Certified in Addiction Medicine and coordinates the Medication Assisted Treatment (MAT) prescriber group at GIMC. She attended the University of Chicago–Pritzker School of Medicine, completed Internal Medicine residency at UCSF in the primary care track based at San Francisco General Hospital, and also spent her Chief Resident year at SFGH. She is an Assistant Clinical Professor at UCSF.
Dr. Jennie Wei, MD, MPH
Dr. Jennie Wei was born and raised in Skokie, Illinois, and has worked with the Indian Health Service at Gallup Indian Medical Center in Gallup, NM since August 2012. She works half of her clinical time on the inpatient side/ICU and half in the outpatient/primary care clinics, which include a transgender clinic. She received her undergraduate, masters in public health and medical school degrees at Harvard. She completed Internal Medicine residency at UCSF in the San Francisco General Primary Care Track, and spent an additional year at San Francisco General Hospital as a Chief Resident. She is Board Certified in Addiction Medicine and leader of a community-wide Alcohol Task Force in Gallup. She is an Assistant Clinical Professor at UCSF.
Dr. Timothy Stenzel MD, PhD
Dr. Timothy Stenzel, MD, PhD directs the FDA’s Office of In Vitro Diagnostics and Radiological Health (OIR) and has an extensive background, spanning more than 20 years, in executive leadership, innovation, companion diagnostics, research and development, FDA regulations, and clinical laboratory operations. He received his M.D. and Ph.D., in Microbiology and Immunology, focusing on the Molecular Biology of DNA Replication, from Duke University after graduating with Honors in Chemistry from Grinnell College. As the OIR Director, Dr. Stenzel advises FDA leadership on all regulatory (pre-market and post-market) for in vitro diagnostics, radiological medical devices, and radiation-emitting product issues that have an impact on Center and Agency level decisions, policy development, nationwide program execution and short and long-range program goals and objectives as well as provide executive leadership and scientific direction to the OIR staff.
Dr. Timothy Stenzel responds to students' questions about the outbreak.